Device manufacturers as controllers – Expanding the concept of ‘controllership’ in the GDPR von Dahi, Alan, Compagnucci, Marcelo Corrales

Volltext

Using Patient Avatars to Promote Health Data Sharing Applications: Perspectives and Regulatory Challenges von Dahi, Alan, Forgó, Nikolaus, Jensen, Sarah, Stauch, Marc

Volltext

Clearview AI und die DSGVO von Marx, Matthias, Dahi, Alan

Volltext

Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation von Prockop, Susan, Doubrovina, Ekaterina, Suser, Stephanie, Heller, Glenn, Barker, Juliet, Dahi, Parastoo, Perales, Miguel A, Papadopoulos, Esperanza, Sauter, Craig, Castro-Malaspina, Hugo, Boulad, Farid, Curran, Kevin J, Giralt, Sergio, Gyurkocza, Boglarka, Hsu, Katharine C, Jakubowski, Ann, Hanash, Alan M, Kernan, Nancy A, Kobos, Rachel, Koehne, Guenther, Landau, Heather, Ponce, Doris, Spitzer, Barbara, Young, James W, Behr, Gerald, Dunphy, Mark, Haque, Sofia, Teruya-Feldstein, Julie, Arcila, Maria, Moung, Christine, Hsu, Susan, Hasan, Aisha, O'Reilly, Richard J

Volltext

A Personalized Whole Genome-Informed Assay Targeting Single Mutant in Circulating Tumor DNA Can Identify MRD and Predict Relapse in DLBCL von Merryman, Reid W., Rhoades, Justin, Xiong, Kan, Antel, Katherine, An, Hyun Hwan, Redd, Robert A., McDonough, Mikaela M., Guerrero, Lillian, Crnjac, Andela, Sridhar, Sainetra, Blewett, Timothy, Chen, Ju, Dahi, Parastoo B., Nieto, Yago, Chen, Yi-Bin, Herrera, Alex F., Joyce, Robin M., Armand, Philippe, Murakami, Mark Alan, Adalsteinsson, Viktor

Volltext

High progression-free survival after intermediate intensity double unit cord blood transplantation in adults von Barker, Juliet N., Devlin, Sean M., Naputo, Kristine A., Skinner, Kelcey, Maloy, Molly A., Flynn, Lisa, Anagnostou, Theodora, Avecilla, Scott T., Scaradavou, Andromachi, Cho, Christina, Dahi, Parastoo B., Giralt, Sergio A., Gyurkocza, Boglarka, Hanash, Alan M., Hsu, Katharine, Jakubowski, Ann A., Papadopoulos, Esperanza B., Peled, Jonathan U., Perales, Miguel-Angel, Sauter, Craig S., Shah, Gunjan L., Shaffer, Brian C., Tamari, Roni, Young, James W., Roshal, Mikhail, O'Reilly, Richard J., Ponce, Doris M., Politikos, Ioannis

Volltext

Low Dose Unfractionated Heparin (UFH) Prophylaxis Is a Safe Strategy for the Prevention of Hepatic Sinusoidal Obstruction Syndrome (SOS) in Adult Allogeneic Stem Cell Transplant (H... von Bhatt, Valkal, Palazzo, Meighan, Kilroy, Kathleen, Hilden, Patrick, Maloy, Molly, Barker, Juliet N., Castro-Malaspina, Hugo R., Chung, David J, Dahi, Parastoo B, Hsu, Katharine C., Hanash, Alan M, Jakubowski, Ann A., Jenq, Robert R., Koehne, Guenther, Landau, Heather, Papadopoulos, Esperanza B, Perales, Miguel-Angel, Sauter, Craig S., Tamari, Roni, van den Brink, Marcel, Young, James W., Giralt, Sergio A., Ponce, Doris M

Volltext

Addition of Tocilizumab to Cyclosporine-a/ Mycophenolate Mofetil (CSA/ MMF) Graft-Vs-Host Disease (GVHD) Prophylaxis Significantly Abrogates Pre-Engraftment Syndrome (PES) & Severe... von Politikos, Ioannis, Maloy, Molly A., Devlin, Sean M., Naputo, Kristine, Bhatt, Valkal, Skinner, Kelcey, Cho, Christina, Dahi, Parastoo B., Giralt, Sergio A., Gyurkocza, Boglarka, Hanash, Alan M., Jakubowski, Ann A., Papadopoulos, Esperanza B., Perales, Miguel, Peled, Jonathan U., Sauter, Craig S., Scordo, Michael, Shah, Gunjan L., Tamari, Roni, Ponce, Doris M., Barker, Juliet N.

Volltext

Low Dose Unfractionated Heparin (UFH) Prophylaxis Is a Feasible Strategy for the Prevention of Hepatic Sinusoidal Obstruction Syndrome (SOS) after Myeloablative Adult Allogeneic He... von Bhatt, Valkal, PharmD, Palazzo, Meighan, ANP-C, Kilroy, Kathleen, ANP-C, Hilden, Patrick, PhD, Devlin, Sean M., PhD, Maloy, Molly, MS, Barker, Juliet N., MBBS, Castro-Malaspina, Hugo, MD, Chung, David J., MD, PhD, Dahi, Parastoo, MD, Hsu, Katharine C., MD, PhD, Hanash, Alan M., MD, PhD, Jakubowski, Ann A., PhD, MD, Jenq, Robert, MD, Koehne, Guenther, MD, PhD, Landau, Heather, MD, Papadopoulos, Esperanza, MD, Perales, Miguel-Angel, MD, Sauter, Craig S., MD, Tamari, Roni, MD, van den Brink, Marcel R.M., MD, PhD, Young, James W., MD, FACP, Giralt, Sergio A., MD, Ponce, Doris M., MD

Volltext

Therapeutic Cyclosporine-a (CSA) Levels in the First 7 Days after Cord Blood Transplantation (CBT) Are Critical to Prevent Severe Acute Graft-Versus-Host Disease (aGVHD) von Bhatt, Valkal, Politikos, Ioannis, Devlin, Sean M., Jacob, Alexandra G., Maloy, Molly, Naputo, Kristine, Afuye, Aishat, Scaradavou, Andromachi, O'Reilly, Richard J., Castro-Malaspina, Hugo, Dahi, Parastoo B., Giralt, Sergio A., Gyurkocza, Boglarka, Jakubowski, Ann A., Papadopoulos, Esperanza B., Peled, Jonathan U., Hanash, Alan M., Perales, Miguel-Angel, Sauter, Craig S., Shaffer, Brian C., Shah, Gunjan L., Tamari, Roni, van den Brink, Marcel R.M., Young, James W., Ponce, Doris M., Barker, Juliet N.

Volltext

198 - Therapeutic Cyclosporine-a (CSA) Levels in the First 7 Days after Cord Blood Transplantation (CBT) Are Critical to Prevent Severe Acute Graft-Versus-Host Disease (aGVHD) von Bhatt, Valkal, Politikos, Ioannis, Devlin, Sean M., Jacob, Alexandra G., Maloy, Molly, Naputo, Kristine, Afuye, Aishat, Scaradavou, Andromachi, O'Reilly, Richard J., Castro-Malaspina, Hugo, Dahi, Parastoo B., Giralt, Sergio A., Gyurkocza, Boglarka, Jakubowski, Ann A., Papadopoulos, Esperanza B., Peled, Jonathan U., Hanash, Alan M., Perales, Miguel-Angel, Sauter, Craig S., Shaffer, Brian C., Shah, Gunjan L., Tamari, Roni, van den Brink, Marcel R.M., Young, James W., Ponce, Doris M., Barker, Juliet N.

Volltext